Scleroderma is a chronic autoimmune disease characterized by the hardening and tightening of the skin and connective tissues. It can also affect internal organs such as the lungs, kidneys, and digestive system. Research in scleroderma aims to better understand the underlying causes of the disease, improve diagnostic tools, develop more effective treatments, and ultimately find a cure. Studies often focus on the role of the immune system in driving the excessive production of collagen and other proteins that lead to tissue fibrosis. Treatment options for scleroderma currently include medications to manage symptoms, physical therapy to maintain mobility, and in severe cases, organ transplants. Research in this field is critical to improving the quality of life for individuals living with scleroderma and ultimately finding a cure for this challenging disease.